STERIS plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
STERIS plc (STE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $2.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-07
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $2.60M, a 72.34% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $3.80M, a 37.70% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $15.00M, a 7400.00% increase year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $8.50M, a 29.17% decline year-over-year.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $36.70M, a 19.54% increase from fiscal 2025.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $30.70M, a 68.68% increase from fiscal 2024.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $18.20M, a 179.91% increase from fiscal 2023.
- STERIS plc share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $6.50M, a 87.72% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-08-07 | $6.40M derived: sum of 2 quarters · filed 2026-08-07 | $21.40M derived: sum of 3 quarters · filed 2026-08-07 | $29.90M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $18.80M derived: sum of 2 quarters · filed 2026-05-29 | $27.30M derived: sum of 3 quarters · filed 2026-05-29 | $36.70M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $23.50M derived: sum of 2 quarters · filed 2026-02-06 | $32.90M 10-Q · filed 2026-02-06 | $39.00M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $17.90M 10-Q · filed 2025-11-06 | $24.00M derived: sum of 3 quarters · filed 2026-08-07 | $24.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $9.40M 10-Q · filed 2026-08-07 | $15.50M derived: sum of 2 quarters · filed 2026-08-07 | $15.70M derived: sum of 3 quarters · filed 2026-08-07 | $27.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $6.30M derived: sum of 2 quarters · filed 2026-05-29 | $18.30M derived: sum of 3 quarters · filed 2026-05-29 | $30.70M 10-K · filed 2026-05-29 | $30.73M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $12.20M derived: sum of 2 quarters · filed 2026-02-06 | $24.60M 10-Q · filed 2026-02-06 | $24.65M 10-Q · filed 2025-02-07 | $34.45M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $24.40M 10-Q · filed 2025-11-06 | $24.45M 10-Q · filed 2024-11-07 | $34.25M derived: sum of 3 quarters · filed 2026-05-29 | $36.13M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | $12.40M 10-Q · filed 2025-08-07 | $12.37M 10-Q · filed 2024-08-08 | $22.25M derived: sum of 2 quarters · filed 2026-05-29 | $24.13M derived: sum of 3 quarters · filed 2026-05-29 | $25.77M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $11.73M derived: sum of 2 quarters · filed 2026-05-29 | $13.37M derived: sum of 3 quarters · filed 2026-05-29 | $18.20M 10-K · filed 2026-05-29 | $18.18M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $3.52M derived: sum of 2 quarters · filed 2025-02-07 | $8.35M 10-Q · filed 2025-02-07 | $10.21M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $6.47M 10-Q · filed 2024-11-07 | $8.33M derived: sum of 3 quarters · filed 2025-05-29 | $8.42M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $4.83M 10-Q · filed 2024-08-08 | $6.70M derived: sum of 2 quarters · filed 2025-05-29 | $6.78M derived: sum of 3 quarters · filed 2025-05-29 | $7.44M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $1.95M derived: sum of 2 quarters · filed 2025-05-29 | $2.60M derived: sum of 3 quarters · filed 2025-05-29 | $6.50M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $741.00K derived: sum of 2 quarters · filed 2024-02-08 | $4.64M 10-Q · filed 2024-02-08 | $14.16M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $4.55M 10-Q · filed 2023-11-07 | $14.08M derived: sum of 3 quarters · filed 2024-05-29 | $41.43M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $3.90M 10-Q · filed 2023-08-08 | $13.42M derived: sum of 2 quarters · filed 2024-05-29 | $40.77M derived: sum of 3 quarters · filed 2024-05-29 | $51.38M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $36.88M derived: sum of 2 quarters · filed 2024-05-29 | $47.48M derived: sum of 3 quarters · filed 2024-05-29 | $52.95M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $27.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | $37.96M derived: sum of 2 quarters · filed 2023-02-08 | $43.42M 10-Q · filed 2023-02-08 | $45.63M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $16.08M 10-Q · filed 2022-11-09 | $18.28M derived: sum of 3 quarters · filed 2023-05-26 | $29.89M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $5.47M 10-Q · filed 2022-08-08 | $7.67M derived: sum of 2 quarters · filed 2023-05-26 | $19.28M derived: sum of 3 quarters · filed 2023-05-26 | $34.94M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $13.81M derived: sum of 2 quarters · filed 2023-05-26 | $29.47M derived: sum of 3 quarters · filed 2023-05-26 | $39.05M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $11.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $27.27M derived: sum of 2 quarters · filed 2022-02-09 | $36.85M 10-Q · filed 2022-02-09 | $57.59M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $15.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $25.24M 10-Q · filed 2021-11-08 | $45.99M derived: sum of 3 quarters · filed 2022-05-31 | $47.04M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $9.58M 10-Q · filed 2021-08-09 | $30.32M derived: sum of 2 quarters · filed 2022-05-31 | $31.38M derived: sum of 3 quarters · filed 2022-05-31 | $48.42M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $20.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $21.80M derived: sum of 2 quarters · filed 2022-05-31 | $38.84M derived: sum of 3 quarters · filed 2022-05-31 | $57.68M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $18.10M derived: sum of 2 quarters · filed 2021-02-09 | $36.94M 10-Q · filed 2021-02-09 | $48.54M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $17.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $35.89M 10-Q · filed 2020-11-06 | $47.48M derived: sum of 3 quarters · filed 2021-05-28 | $54.04M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $18.84M 10-Q · filed 2020-08-07 | $30.44M derived: sum of 2 quarters · filed 2021-05-28 | $37.00M derived: sum of 3 quarters · filed 2021-05-28 | $39.63M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $11.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $18.16M derived: sum of 2 quarters · filed 2021-05-28 | $20.79M derived: sum of 3 quarters · filed 2021-05-28 | $25.37M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $6.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $9.19M derived: sum of 2 quarters · filed 2020-02-10 | $13.77M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $7.22M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $4.58M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $16.10M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $6.45M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |